Education
About Us
Working with TipRanks
Follow Us
Andreas Pahl Insider Profile
4 Followers
Andreas Pahl, Chief Executive Officer at Heidelberg Pharma AG, holds ― shares in Heidelberg Pharma AG (Ticker: GB:0QW5).
Andreas Pahl Heidelberg Pharma AG (0QW5)Chief Executive Officer
Heidelberg Pharma AG (0QW5)
Chief Executive Officer
Ranked #59,915 out of 106,487 Corporate Insiders
Profitable Transactions
1 out of 8 Profitable Transactions
Average Return
-2.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Andreas Pahl does not currently own shares as a corporate insider.
A breakdown of Andreas Pahl's holdings
Insider Roles
Chief Executive Officer
Roles that Andreas Pahl holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 06, 2019 - Dec 06, 2020
Return:+33.00%
The most profitable trade made by Andreas Pahl
Andreas Pahl's Trading History
List of latest transactions for each holding click on a transaction to see Andreas Pahl's performance on stock
You May Also Like
Andreas Pahl insider profile FAQ
What is the percentage of profitable transactions made by Andreas Pahl?
The percentage of profitable transactions made by Andreas Pahl is 13%.
What is the average return per transaction made by Andreas Pahl?
The average return per transaction made by Andreas Pahl is -2.40%.
What stocks does Andreas Pahl hold?
Andreas Pahl holds: GB:0QW5 stocks.
What was Andreas Pahl’s latest transaction?
Andreas Pahl latest transaction was an Uninformative Sell of €170.10K.
What was Andreas Pahl's most profitable transaction?
Andreas Pahl’s most profitable transaction was an Informative Buy of GB:0QW5 stock on December 6, 2019. The return on the trade was 33.00%.
What is Andreas Pahl's role in Heidelberg Pharma AG?
Andreas Pahl's role in Heidelberg Pharma AG is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.